EU Launches Safety Review Of Finasteride And Dutasteride Over Suicidal Thoughts And Behavior

Businessman showing risk level indicator rating since low to high for risk management and assessment review concept
The EU is weighing the risks of two 5-alpha reductase inhibitors • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography